000 | 01662 a2200481 4500 | ||
---|---|---|---|
005 | 20250515185120.0 | ||
264 | 0 | _c20100105 | |
008 | 201001s 0 0 eng d | ||
022 | _a1464-3405 | ||
024 | 7 |
_a10.1016/j.bmcl.2009.08.080 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMowbray, Charles E | |
245 | 0 | 0 |
_aPyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cOct 2009 |
||
300 |
_a5857-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdrug therapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-HIV Agents _xchemical synthesis |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aDrug Resistance, Viral |
650 | 0 | 4 |
_aHIV Reverse Transcriptase _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMicrosomes, Liver _xmetabolism |
650 | 0 | 4 |
_aNitriles _xchemical synthesis |
650 | 0 | 4 |
_aPyrazoles _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xchemical synthesis |
700 | 1 | _aBurt, Catherine | |
700 | 1 | _aCorbau, Romuald | |
700 | 1 | _aGayton, Simon | |
700 | 1 | _aHawes, Michael | |
700 | 1 | _aPerros, Manos | |
700 | 1 | _aTran, Isabelle | |
700 | 1 | _aPrice, David A | |
700 | 1 | _aQuinton, Faye J | |
700 | 1 | _aSelby, Matthew D | |
700 | 1 | _aStupple, Paul A | |
700 | 1 | _aWebster, Rob | |
700 | 1 | _aWood, Anthony | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 19 _gno. 20 _gp. 5857-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2009.08.080 _zAvailable from publisher's website |
999 |
_c19147035 _d19147035 |